Lykis Board of Directors

Get the latest insights into the leadership at Lykis. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Nadir Dhrolia Chairman & Managing Director
Mr. Mitesh Agrawal Ind. Non-Executive Director
Mr. Rajendra Singh Singhvi Ind. Non-Executive Director
Mr. Kairav Trivedi Ind. Non-Executive Director
Mr. Rajesh Nambiar Ind. Non-Executive Director
Mrs. Mangala Prabhu Ind. Non-Executive Director
Mr. Deep Shah Non Exe.Non Ind.Director

Lykis Share price

LYKISLTD

38.88

0.00 (0.00%)
Last updated on 25 Sep, 2025 | 07:50 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

25.30

52 Week High

53.99

The current prices are delayed, login to your account for live prices

Lykis FAQs

The board at Lykis consists of experienced professionals, including Mr. Nadir Dhrolia , Mr. Mitesh Agrawal , and others, overseeing the company’s strategic and corporate governance.

Directors at Lykis are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Nadir Dhrolia is the current chairman at Lykis.

Executive directors at Lykis are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Lykis adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Lykis, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.